Latest Regulatory Milestones News

Algorae Pharmaceuticals has reached a key regulatory milestone as the TGA accepts its initial registration dossier, paving the way for potential commercialisation of its generic medicines in Australia and New Zealand.

NH3 Clean Energy has entered a pivotal phase in its WAH2 Project development, partnering with global engineering giant Linde and progressing funding discussions to secure up to A$567 million. This collaboration aims to reduce capital and operational risks as the project moves closer to a final investment decision.

Everest Metals Corporation has reported promising metallurgical test results for its Mt Edon Critical Mineral Project, alongside submitting a key Mining Proposal to regulators, signalling progress toward commercial development.

Paladin Energy faces a judicial review application from the Métis Nation–Saskatchewan contesting the recent environmental approval for its Patterson Lake South Project. The legal challenge alleges insufficient Indigenous consultation and seeks to halt project progress.

Optiscan Imaging Ltd has taken a significant step towards commercialising its InSpecta® veterinary imaging device in the US by submitting a regulatory dossier to the FDA. This milestone not only initiates formal review but also sets the stage for broader clinical adoption and future device approvals.

Papua New Guinea’s Conservation and Environment Protection Authority has approved an updated Environment Permit for Geopacific Resources’ Woodlark Gold Project, enabling increased throughput and signalling strong government backing ahead of a key feasibility study.

Alterity Therapeutics has secured encouraging regulatory feedback from the FDA on its ATH434 Phase 3 program for Multiple System Atrophy, marking a critical step towards pivotal trial initiation.

Atomo Diagnostics stands to gain significantly as Lumos Diagnostics’ FebriDx test secures FDA CLIA waiver approval, vastly expanding its US market potential. This regulatory milestone triggers substantial contracted revenues and prompts Atomo to ramp up production.

EML Payments has appointed Adam Olding as its Global CEO, marking a pivotal step in its EML 2.0 transformation and signalling strengthened leadership to drive growth. Concurrently, regulatory developments around its Australian banking licence application introduce new compliance dynamics.

Boab Metals has received the crucial regulatory green light for its Sorby Hills project, clearing the way for full-scale mining operations and first concentrate production targeted in late 2027.

4DMedical has achieved CE Mark certification for its groundbreaking CT:VQ™ ventilation-perfusion imaging technology, unlocking the vast European market. The company also raised $83 million to fund rapid expansion across the EU.

Finder Energy has achieved a pivotal regulatory milestone with approval of the Development Area for its Kuda Tasi and Jahal oil fields, setting the stage for project sanction and a scalable production hub in Timor-Leste.